These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3027798)

  • 1. Responses of cats to nasal vaccination with a live, modified feline herpesvirus type 1.
    Cocker FM; Newby TJ; Gaskell RM; Evans PA; Gaskell CJ; Stokes CR; Harbour DA; Bourne JF
    Res Vet Sci; 1986 Nov; 41(3):323-30. PubMed ID: 3027798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Onset of immunity in kittens after vaccination with a non-adjuvanted vaccine against feline panleucopenia, feline calicivirus and feline herpesvirus.
    Jas D; Aeberlé C; Lacombe V; Guiot AL; Poulet H
    Vet J; 2009 Oct; 182(1):86-93. PubMed ID: 18694649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination of cats for feline rhinotracheitis results in a quantitative reduction of virulent feline herpesvirus-1 latency load after challenge.
    Sussman MD; Maes RK; Kruger JM
    Virology; 1997 Feb; 228(2):379-82. PubMed ID: 9123845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenic and protective effects of the F-2 strain of feline viral rhinotracheitis virus.
    Bittle JL; Rubic WJ
    Am J Vet Res; 1975 Jan; 36(1):89-91. PubMed ID: 163604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination against feline viral rhinotracheitis in kittens with maternally derived feline viral rhinotracheitis antibodies.
    Johnson RP; Povey RC
    J Am Vet Med Assoc; 1985 Jan; 186(2):149-52. PubMed ID: 2982774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of feral cats to vaccination at the time of neutering.
    Fischer SM; Quest CM; Dubovi EJ; Davis RD; Tucker SJ; Friary JA; Crawford PC; Ricke TA; Levy JK
    J Am Vet Med Assoc; 2007 Jan; 230(1):52-8. PubMed ID: 17199493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a feline viral rhinotracheitis-feline calicivirus disease vaccine.
    Scott FW
    Am J Vet Res; 1977 Feb; 38(2):229-34. PubMed ID: 190925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term immunity in cats vaccinated with an inactivated trivalent vaccine.
    Scott FW; Geissinger CM
    Am J Vet Res; 1999 May; 60(5):652-8. PubMed ID: 10328440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-year duration of immunity in cats following vaccination against feline rhinotracheitis virus, feline calicivirus, and feline panleukopenia virus.
    Gore TC; Lakshmanan N; Williams JR; Jirjis FF; Chester ST; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
    Vet Ther; 2006; 7(3):213-22. PubMed ID: 17039444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of viremia associated with experimental primary feline herpesvirus infection or presumed herpetic recrudescence in cats.
    Westermeyer HD; Thomasy SM; Kado-Fong H; Maggs DJ
    Am J Vet Res; 2009 Jan; 70(1):99-104. PubMed ID: 19119954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of modified live or inactivated feline herpesvirus-1 parenteral vaccines on clinical and laboratory findings following viral challenge.
    Summers SC; Ruch-Gallie R; Hawley JR; Lappin MR
    J Feline Med Surg; 2017 Aug; 19(8):824-830. PubMed ID: 27432436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Questions efficacy of vaccinating cats at 3-year intervals.
    Norsworthy GD
    Am J Vet Res; 1999 Aug; 60(8):918-9. PubMed ID: 10451196
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of intranasal administration of a modified live feline herpesvirus 1 and feline calicivirus vaccine against disease caused by Bordetella bronchiseptica after experimental challenge.
    Bradley A; Kinyon J; Frana T; Bolte D; Hyatt DR; Lappin MR
    J Vet Intern Med; 2012; 26(5):1121-5. PubMed ID: 22860699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of an intranasal combined feline viral rhinotracheitis, feline calicivirus vaccine and the FVR carrier state.
    Orr CM; Gaskell CJ; Gaskell RM
    Vet Rec; 1980 Feb; 106(8):164-6. PubMed ID: 6244692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of anesthesia and surgery on serologic responses to vaccination in kittens.
    Reese MJ; Patterson EV; Tucker SJ; Dubovi EJ; Davis RD; Crawford PC; Levy JK
    J Am Vet Med Assoc; 2008 Jul; 233(1):116-21. PubMed ID: 18593319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-year duration of immunity for feline herpesvirus and calicivirus evaluated in a controlled vaccination-challenge laboratory trial.
    Jas D; Frances-Duvert V; Vernes D; Guigal PM; Poulet H
    Vet Microbiol; 2015 May; 177(1-2):123-31. PubMed ID: 25824128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment with feline interferon omega and the course of subsequent infection with feline herpesvirus in cats.
    Haid C; Kaps S; Gönczi E; Hässig M; Metzler A; Spiess BM; Richter M
    Vet Ophthalmol; 2007; 10(5):278-84. PubMed ID: 17760705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feline herpesvirus type-1 transcription is associated with increased nasal cytokine gene transcription in cats.
    Johnson LR; Maggs DJ
    Vet Microbiol; 2005 Jul; 108(3-4):225-33. PubMed ID: 15939557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of two commercial feline rhinotracheitis-calicivirus-panleukopenia vaccines.
    Povey RC
    Can Vet J; 1979 Oct; 20(10):253-60. PubMed ID: 232426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A feline herpesvirus-1 recombinant with a deletion in the genes for glycoproteins gI and gE is effective as a vaccine for feline rhinotracheitis.
    Sussman MD; Maes RK; Kruger JM; Spatz SJ; Venta PJ
    Virology; 1995 Dec; 214(1):12-20. PubMed ID: 8525607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.